مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

205
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Development and Evaluation of Drug Monitoring System for Multiple Sclerosis Patients

Pages

  465-475

Abstract

 Background and Aim: Taking a wide range of Medications in Multiple Sclerosis (MS) patients can lead to side effects and drug interactions. Therefore, the use of intelligent systems such as drug Monitoring Systems can help in the effective and timely treatment of MS disease. In this regard, the present study was conducted to design, development, and evaluation of the drug Monitoring System for Multiple Sclerosis patients. Materials and Methods: The present descriptive-developmental study was performed in four stages. In the first stage, by searching the library resources and valid guidelines, the minimum data set was determined and provided to neurologists and MS fellowships in the form of checklists for validation. Then the software was designed logically and coded based on the opinion of experts. In the last stage, the software was evaluated by end-users. Results: The information elements in the software design were categorized into patient demographic information, medical history, clinical signs, imaging procedures, laboratory tests for ocrelizumab and fingolimod drugs, counseling, and treatment data. Finally, the performance of the drug Monitoring System was evaluated with an average of 7. 9 and was approved by users. Conclusion: The results of software evaluation showed that the drug Monitoring System can help general practitioners, neurologists, and MS fellowships in monitoring and follow-up of patients and lead to increased patient safety.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    SAFDARI, REZA, NASER MOGHADASI, ABDORREZA, Khenarinezhad, Sahar, & Ghazanfari Savadkoohi, Ehsan. (2021). Development and Evaluation of Drug Monitoring System for Multiple Sclerosis Patients. PAYAVARD-SALAMAT, 14(5 ), 465-475. SID. https://sid.ir/paper/416230/en

    Vancouver: Copy

    SAFDARI REZA, NASER MOGHADASI ABDORREZA, Khenarinezhad Sahar, Ghazanfari Savadkoohi Ehsan. Development and Evaluation of Drug Monitoring System for Multiple Sclerosis Patients. PAYAVARD-SALAMAT[Internet]. 2021;14(5 ):465-475. Available from: https://sid.ir/paper/416230/en

    IEEE: Copy

    REZA SAFDARI, ABDORREZA NASER MOGHADASI, Sahar Khenarinezhad, and Ehsan Ghazanfari Savadkoohi, “Development and Evaluation of Drug Monitoring System for Multiple Sclerosis Patients,” PAYAVARD-SALAMAT, vol. 14, no. 5 , pp. 465–475, 2021, [Online]. Available: https://sid.ir/paper/416230/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button